Clinical Trials Browser

Phase 4 × Cholangiocarcinoma × lenvatinib × Clear all

NCT06417606 2024-05-22

Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma

Phase 4 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma